Conference Description
Key Takeaways
- Event focus: Pharmaceutical supply chain resilience, serialisation, traceability, and anti-counterfeiting strategies
- Primary audience: Supply chain executives, regulatory professionals, technology providers, and pharmaceutical manufacturers
- Regulatory themes: DSCSA compliance, EU Falsified Medicines Directive, and global serialisation mandates
- Technology coverage: Blockchain, IoT, artificial intelligence, machine learning, and intelligent automation
- Industry challenges: Counterfeit drug prevention, cold chain integrity, end-to-end visibility, and sustainable packaging
Introduction
Pharma Supply Chain & Security World 2027 returns to London for its ninth edition, convening pharmaceutical supply chain professionals, regulatory authorities, and technology specialists to examine the operational and compliance challenges facing global drug distribution networks. The conference addresses serialisation requirements, traceability infrastructure, packaging innovation, and logistics optimisation at a time when regulatory deadlines, supply chain disruptions, and counterfeit drug proliferation continue to pressure the industry.
The pharmaceutical supply chain has grown increasingly complex as manufacturers navigate divergent regional regulations, heightened patient safety expectations, and the need for real-time visibility across multi-tier supplier networks. This event provides a forum for examining how emerging technologies and collaborative frameworks can address these interconnected challenges.
About This Event
Organised by Corvus Global Events, this London-based conference brings together decision-makers from pharmaceutical manufacturing, contract packaging, logistics, regulatory enforcement, and technology development. The programme spans supply chain optimisation, digital transformation, and security strategies designed to protect product integrity from manufacturing through final distribution.
The event structure facilitates knowledge exchange through case studies, strategic presentations, and discussions of implementation experiences. Participants gain exposure to both established best practices and emerging approaches that address the evolving regulatory and operational landscape.
Serialisation and Traceability as Regulatory Imperatives
Serialisation remains central to pharmaceutical supply chain compliance, with the United States Drug Supply Chain Security Act and the European Union Falsified Medicines Directive establishing distinct but overlapping requirements for product identification and verification. The conference examines strategies for developing sustainable serialisation programmes that satisfy multiple regulatory frameworks while generating operational value beyond compliance.
Track and trace solutions have matured significantly since initial implementation deadlines, yet many organisations continue to refine their integration of serialisation data into broader supply chain operations. Sessions address how analytics applied to serialisation data can improve demand forecasting, inventory management, and supply chain agility. The transition from compliance-driven serialisation to data-driven supply chain intelligence represents a significant opportunity for organisations that have already invested in foundational infrastructure.
End-to-end visibility across supply chain partners requires not only technical interoperability but also governance frameworks that define data sharing responsibilities and access controls. The conference explores how organisations are structuring these collaborative arrangements while protecting commercially sensitive information.
Combatting Counterfeit Pharmaceuticals
Pharmaceutical counterfeiting poses serious risks to patient safety and brand integrity, with criminal networks exploiting gaps in supply chain visibility and authentication capabilities. The conference addresses anti-counterfeiting strategies at multiple levels, from tamper-evident packaging features to enterprise-scale authentication technologies and cross-border enforcement coordination.
Effective brand protection requires synchronisation between pharmaceutical manufacturers, regulatory agencies, customs authorities, and law enforcement. Sessions examine how industry associations and professional bodies coordinate with government agencies to identify and disrupt counterfeit supply chains. The role of intellectual property enforcement, trademark protection, and regulatory action in supporting these efforts receives particular attention.
The internet has created new distribution channels for counterfeit products, enabling criminal actors to reach consumers directly while evading traditional supply chain controls. The conference explores strategies for monitoring online marketplaces, coordinating takedown efforts, and raising public awareness about the risks of purchasing pharmaceuticals from unverified sources.
Digital Transformation and Emerging Technologies
Industry 4.0 principles are reshaping pharmaceutical manufacturing and distribution, with intelligent automation, IoT sensors, and advanced analytics enabling new levels of operational efficiency and quality control. The conference examines how these technologies integrate with existing infrastructure and what organisational capabilities are required for successful adoption.
Blockchain technology has attracted considerable interest for its potential to create immutable records of product movement and custody transfers across supply chain partners. While implementation remains uneven across the industry, the conference provides an opportunity to assess real-world deployments and evaluate where distributed ledger technology delivers meaningful advantages over conventional database architectures.
Artificial intelligence and machine learning applications in supply chain management continue to expand, from demand forecasting and inventory optimisation to anomaly detection in serialisation data that may indicate diversion or counterfeiting. Understanding the data requirements, model validation approaches, and integration challenges associated with these technologies helps organisations make informed investment decisions.
Packaging, Labelling, and Cold Chain Considerations
Smart packaging technologies increasingly incorporate sensors, indicators, and digital identifiers that provide information about product condition and authenticity. The conference addresses how these capabilities complement serialisation requirements while delivering additional value through temperature monitoring, tamper detection, and patient engagement features.
Artwork management and labelling compliance present ongoing challenges as organisations manage product portfolios across multiple markets with varying regulatory requirements. Streamlined processes for artwork creation, review, and approval help reduce time-to-market while minimising compliance risks associated with labelling errors.
Cold chain logistics for temperature-sensitive products require specialised infrastructure, monitoring capabilities, and contingency planning. The intersection of cold chain requirements with serialisation and traceability obligations creates additional complexity that the conference addresses through examination of integrated approaches.
Risk Management and Supply Chain Resilience
Developing comprehensive risk management programmes for pharmaceutical supply chains requires systematic identification of vulnerabilities, assessment of potential impacts, and implementation of mitigation strategies. The conference examines how organisations structure their risk management functions and integrate brand protection, product security, and patient safety considerations into unified frameworks.
Supply chain network design decisions have long-term implications for operational flexibility, cost structure, and risk exposure. Sessions address analytical approaches for optimising network configuration while maintaining the resilience needed to respond to disruptions.
Who Should Attend
The conference serves professionals across the pharmaceutical supply chain ecosystem, including supply chain and operations executives from pharmaceutical manufacturers and distributors, serialisation and track-and-trace specialists, packaging and labelling professionals, quality and compliance managers, and digital innovation leaders focused on blockchain, artificial intelligence, and data analytics.
Representatives from contract manufacturing organisations, contract packaging organisations, logistics providers, and technology vendors will find relevant content addressing their roles in the broader supply chain network. Regulatory officials, customs authorities, intellectual property specialists, and anti-counterfeiting professionals contribute enforcement and policy perspectives that inform industry approaches.
Conclusion
Pharma Supply Chain & Security World 2027 addresses the convergence of regulatory compliance, technological innovation, and security imperatives that define contemporary pharmaceutical logistics. As the industry continues adapting to evolving serialisation requirements, counterfeit threats, and digital transformation opportunities, forums that facilitate cross-functional dialogue and practical knowledge exchange serve an essential role in advancing collective capabilities.